Exact Mass: 356.0653

Exact Mass Matches: 356.0653

Found 65 metabolites which its exact mass value is equals to given mass value 356.0653, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5-Amino-6-(5'-phosphoribitylamino)uracil

{[(2R,3S,4S)-5-[(5-amino-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino]-2,3,4-trihydroxypentyl]oxy}phosphonic acid

C9H17N4O9P (356.0733)


5-Amino-6-(5-phosphoribitylamino)uracil belongs to the class of organic compounds known as monosaccharide phosphates. These are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 5-Amino-6-(5-phosphoribitylamino)uracil is an extremely weak basic (essentially neutral) compound (based on its pKa). 5-Amino-6-(5-phosphoribitylamino)uracil has been detected, but not quantified in, several different foods, such as sapodilla, kumquats, sacred lotus, Persian limes, and Cascade huckleberries. This could make 5-amino-6-(5-phosphoribitylamino)uracil a potential biomarker for the consumption of these foods. 5-Amino-6-(5-phosphoribitylamino)uracil is an intermediate in riboflavin metabolism. 5-Amino-6-(5-phosphoribitylamino)uracil is the third to last step in the synthesis of 7-hydroxy-6-methyl-8-ribityl lumazine and is converted from 5-amino-6-(5-phosphoribosylamino)uracil via the enzyme 5-amino-6-(5-phosphoribosylamino)uracil reductase (EC 1.1.1.193). It is then converted into 4-(1-D-ribitylamino)-5-amino-2,6-dihydroxypyrimidine via a hydrolase enzyme (EC 3.1.3.- ). 5-amino-6-(5-phospho-d-ribitylamino)uracil is a member of the class of compounds known as monosaccharide phosphates. Monosaccharide phosphates are monosaccharides comprising a phosphated group linked to the carbohydrate unit. 5-amino-6-(5-phospho-d-ribitylamino)uracil is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 5-amino-6-(5-phospho-d-ribitylamino)uracil can be found in a number of food items such as star fruit, chinese cabbage, mamey sapote, and sapodilla, which makes 5-amino-6-(5-phospho-d-ribitylamino)uracil a potential biomarker for the consumption of these food products. 5-amino-6-(5-phospho-d-ribitylamino)uracil exists in E.coli (prokaryote) and yeast (eukaryote).

   

IAA-94

(S)-2-((6,7-Dichloro-2-cyclopentyl-2-methyl-1-oxo-2,3-dihydro-1H-inden-5-yl)oxy)acetic acid

C17H18Cl2O4 (356.0582)


D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

Caffeic acid 3-O-glucuronide

(2S,3S,4S,5R,6S)-6-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


Caffeic acid 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

Caffeic acid 4-O-glucuronide

(2S,3S,4S,5R,6S)-6-{4-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


Caffeic acid 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

Caffeoyl C1-glucuronide

(2S,3S,4S,5R,6S)-6-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


Caffeoyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).

   

3,5-Dihydroxycinnamic acid glucuronide

(2R,4R,6R)-6-{3-[(1E)-2-carboxyeth-1-en-1-yl]-5-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

(S)-2-((6,7-Dichloro-2-cyclopentyl-2-methyl-1-oxo-2,3-dihydro-1H-inden-5-yl)oxy)acetic acid

(S)-2-((6,7-Dichloro-2-cyclopentyl-2-methyl-1-oxo-2,3-dihydro-1H-inden-5-yl)oxy)acetic acid

C17H18Cl2O4 (356.0582)


   

3-Hydroxycymopolone

(-)-3-Hydroxycymopolone

C16H21BrO4 (356.0623)


   

7-Hydroxycymopochromanone

(-)-7-Hydroxycymopochromanone

C16H21BrO4 (356.0623)


   
   

Coumaroyl + C6H9O8 (isomer of 844, 845, 846)

Coumaroyl + C6H9O8 (isomer of 844, 845, 846)

C15H16O10 (356.0743)


Annotation level-3

   

Erioside

6,8-Dihydroxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one

C15H16O10 (356.0743)


Erioside is a natural product found in Morus alba and Lasiosiphon glaucus with data available.

   

1-(2,5-Dihydroxy-4-bromophenyl)-3-hydroxy-3,7-dimethyl-6-octene-1-one

1-(2,5-Dihydroxy-4-bromophenyl)-3-hydroxy-3,7-dimethyl-6-octene-1-one

C16H21BrO4 (356.0623)


   

2,2,2-Trifluorethoxy-methylpenicillin

2,2,2-Trifluorethoxy-methylpenicillin

C12H15F3N2O5S (356.0654)


   
   

mulberroside B

mulberroside B

C15H16O10 (356.0743)


   

(7E,9R,10R,13E,15Z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid|xestospongienol K

(7E,9R,10R,13E,15Z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid|xestospongienol K

C16H21BrO4 (356.0623)


   

5,7,8-trihydroxycoumarin-5-beta-glucopyranoside

5,7,8-trihydroxycoumarin-5-beta-glucopyranoside

C15H16O10 (356.0743)


   
   
   

Coumaroyl + C6H9O8 (isomer of 843, 844, 846)

Coumaroyl + C6H9O8 (isomer of 843, 844, 846)

C15H16O10 (356.0743)


Annotation level-3

   

Coumaroyl + C6H9O8 (isomer of 843, 845, 846)

Coumaroyl + C6H9O8 (isomer of 843, 845, 846)

C15H16O10 (356.0743)


Annotation level-3

   

Coumaroyl + C6H9O8 (isomer of 843, 844, 845)

Coumaroyl + C6H9O8 (isomer of 843, 844, 845)

C15H16O10 (356.0743)


Annotation level-3

   

Caffeic acid 3-O-glucuronide

(2S,3S,4S,5R,6S)-6-{5-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

Caffeic acid 4-O-glucuronide

(2S,3S,4S,5R,6S)-6-{4-[(1E)-2-carboxyeth-1-en-1-yl]-2-hydroxyphenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

Caffeoyl C1-glucuronide

(2S,3S,4S,5R,6S)-6-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C15H16O10 (356.0743)


   

4-(6-Bromo-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester

4-(6-Bromo-pyridin-2-yloxy)-piperidine-1-carboxylic acid tert-butyl ester

C15H21BrN2O3 (356.0735)


   

1-(4-Sulfamoylphenyl)-1,6-dihydropyrazolo[3,4-e]indazole-3-carbox amide

1-[4-(Aminosulfonyl)phenyl]-1,6-dihydropyrazolo[3,4-E]indazole-3-carboxamide

C15H12N6O3S (356.0692)


   

fletazepam

fletazepam

C17H13ClF4N2 (356.0703)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

DIFLUFENZOPYR SODIUM SALT

DIFLUFENZOPYR SODIUM SALT

C15H11F2N4NaO3 (356.0697)


   

2,5-bis-Acetoacetamidobenzene sulfonic acid

2,5-bis-Acetoacetamidobenzene sulfonic acid

C14H16N2O7S (356.0678)


   

2,5-bis(diethoxyphosphoryl)thiophene

2,5-bis(diethoxyphosphoryl)thiophene

C12H22O6P2S (356.0612)


   

1-CYCLOPROPYL-5-NITRO-6,7,8-TRIFLUORO-1,4-DIHYDRO-4-OXO-3- QUINOLINECARBOXYLIC ACID ETHYL ESTER

1-CYCLOPROPYL-5-NITRO-6,7,8-TRIFLUORO-1,4-DIHYDRO-4-OXO-3- QUINOLINECARBOXYLIC ACID ETHYL ESTER

C15H11F3N2O5 (356.062)


   

PENTAMETHYL CYCLOPENTADIENE-1,2,3,4,5-PENTACARBOXYLATE

PENTAMETHYL CYCLOPENTADIENE-1,2,3,4,5-PENTACARBOXYLATE

C15H16O10 (356.0743)


   

AICAR phosphate

AICAR phosphate

C9H17N4O9P (356.0733)


AICAR phosphate (Acadesine phosphate) is an adenosine analog and a AMPK activator. AICAR phosphate regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR phosphate is also an autophagy, YAP and mitophagy inhibitor[1][2]. AICAR phosphate (Acadesine phosphate) is an adenosine analog and a AMPK activator. AICAR phosphate regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR phosphate is also an autophagy, YAP and mitophagy inhibitor[1][2]. AICAR phosphate (Acadesine phosphate) is an adenosine analog and a AMPK activator. AICAR phosphate regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR phosphate is also an autophagy, YAP and mitophagy inhibitor[1][2].

   

3,5-Dihydroxycinnamic acid glucuronide

3,5-Dihydroxycinnamic acid glucuronide

C15H16O10 (356.0743)


   

2-[(7-Chloro-4-quinazolinyl)oxy]-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone

2-[(7-Chloro-4-quinazolinyl)oxy]-1-(2,3-dihydro-1,4-benzodioxin-6-yl)ethanone

C18H13ClN2O4 (356.0564)


   

[3-[4-Morpholinyl(sulfanylidene)methyl]-1-indolyl]-thiophen-2-ylmethanone

[3-[4-Morpholinyl(sulfanylidene)methyl]-1-indolyl]-thiophen-2-ylmethanone

C18H16N2O2S2 (356.0653)


   

2-(1,3-Benzothiazol-2-yl)-4-[(4-fluorophenyl)thio]-5-methyl-3-pyrazolamine

2-(1,3-Benzothiazol-2-yl)-4-[(4-fluorophenyl)thio]-5-methyl-3-pyrazolamine

C17H13FN4S2 (356.0566)


   

[3-[2-Hydroxy-3-(2,4,6-trihydroxyphenyl)propyl]phenyl] hydrogen sulate

[3-[2-Hydroxy-3-(2,4,6-trihydroxyphenyl)propyl]phenyl] hydrogen sulate

C15H16O8S (356.0566)


   

[3-Hydroxy-4-(7-methoxy-2-oxochromen-8-yl)-2-methylidenebutyl] hydrogen sulate

[3-Hydroxy-4-(7-methoxy-2-oxochromen-8-yl)-2-methylidenebutyl] hydrogen sulate

C15H16O8S (356.0566)


   

Cobalt triacetylatonate

Cobalt triacetylatonate

C15H21CoO6 (356.067)


   

5-Amino-6-(5-phospho-D-ribitylamino)uracil

5-Amino-6-(5-phospho-D-ribitylamino)uracil

C9H17N4O9P (356.0733)


5-O-Phosphono-D-ribitol in which the hydroxy group at position 1 is substituted by the 6-amino group of 5,6-diaminopyrimidine-2,4(1H,3H)-dione.

   

AminoPhospho-ribitylamino-uracil

AminoPhospho-ribitylamino-uracil

C9H17N4O9P (356.0733)


   

Desformylflustrabromine hydrochloride

Desformylflustrabromine hydrochloride

C16H22BrClN2 (356.0655)


Desformylflustrabromine hydrochloride is a selective agonist of α4β2 neuronal nicotinic acetylcholine receptor (nAChR) with a pEC50 of 6.48.

   

6,8-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

6,8-dihydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

(9r,10s)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9r,10s)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

7-bromo-6-hydroxy-2-(4-hydroxy-4-methylpentyl)-2-methyl-3h-1-benzopyran-4-one

7-bromo-6-hydroxy-2-(4-hydroxy-4-methylpentyl)-2-methyl-3h-1-benzopyran-4-one

C16H21BrO4 (356.0623)


   

(7e,9r,10r,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9r,10r,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

1-(4-bromo-2,5-dihydroxyphenyl)-3-hydroxy-3,7-dimethyloct-6-en-1-one

1-(4-bromo-2,5-dihydroxyphenyl)-3-hydroxy-3,7-dimethyloct-6-en-1-one

C16H21BrO4 (356.0623)


   

(7e,9r,10s,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9r,10s,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

(3r)-1-(4-bromo-2,5-dihydroxyphenyl)-3-hydroxy-3,7-dimethyloct-6-en-1-one

(3r)-1-(4-bromo-2,5-dihydroxyphenyl)-3-hydroxy-3,7-dimethyloct-6-en-1-one

C16H21BrO4 (356.0623)


   

5,7-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

5,7-dihydroxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

(2r)-7-bromo-6-hydroxy-2-(4-hydroxy-4-methylpentyl)-2-methyl-3h-1-benzopyran-4-one

(2r)-7-bromo-6-hydroxy-2-(4-hydroxy-4-methylpentyl)-2-methyl-3h-1-benzopyran-4-one

C16H21BrO4 (356.0623)


   

6,8-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

6,8-dihydroxy-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

(9r,10r)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9r,10r)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

(9s,10s)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9s,10s)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

(7e,9s,10s,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9s,10s,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

1-(4-bromo-2,5-dihydroxyphenyl)-7-hydroxy-3,7-dimethyloct-2-en-1-one

1-(4-bromo-2,5-dihydroxyphenyl)-7-hydroxy-3,7-dimethyloct-2-en-1-one

C16H21BrO4 (356.0623)


   

(7e,9s,10r,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(7e,9s,10r,13e,15z)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

(9s,10r)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

(9s,10r)-16-bromo-9,10-dihydroxyhexadeca-7,13,15-trien-5-ynoic acid

C16H21BrO4 (356.0623)


   

7,8-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

7,8-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)


   

(2e)-1-(4-bromo-2,5-dihydroxyphenyl)-7-hydroxy-3,7-dimethyloct-2-en-1-one

(2e)-1-(4-bromo-2,5-dihydroxyphenyl)-7-hydroxy-3,7-dimethyloct-2-en-1-one

C16H21BrO4 (356.0623)


   

7,8-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

7,8-dihydroxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one

C15H16O10 (356.0743)